The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Docetaxel-Global Market Insights and Sales Trends 2025
Synopsis
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
The global Docetaxel market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Docetaxel in various end use industries. The expanding demands from the Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Others, are propelling Docetaxel market. 20 mg/ml, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 40 mg/ml segment is estimated at % CAGR for the next seven-year period.
China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Docetaxel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Docetaxel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Docetaxel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Docetaxel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Docetaxel covered in this report include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma and Jiangsu Aosaikang Pharma, etc.
The global Docetaxel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Global Docetaxel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Docetaxel market, Segment by Type:
20 mg/ml
40 mg/ml
60 mg/ml
Global Docetaxel market, by Application
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Docetaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
The global Docetaxel market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Docetaxel in various end use industries. The expanding demands from the Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Others, are propelling Docetaxel market. 20 mg/ml, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 40 mg/ml segment is estimated at % CAGR for the next seven-year period.
China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Docetaxel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Docetaxel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Docetaxel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Docetaxel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Docetaxel covered in this report include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma and Jiangsu Aosaikang Pharma, etc.
The global Docetaxel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Global Docetaxel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Docetaxel market, Segment by Type:
20 mg/ml
40 mg/ml
60 mg/ml
Global Docetaxel market, by Application
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Docetaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Docetaxel Market Overview
1.1 Docetaxel Product Overview
1.2 Docetaxel Market Segment by Type
1.2.1 20 mg/ml
1.2.2 40 mg/ml
1.2.3 60 mg/ml
1.3 Global Docetaxel Market Size by Type
1.3.1 Global Docetaxel Market Size Overview by Type (2018-2029)
1.3.2 Global Docetaxel Historic Market Size Review by Type (2018-2023)
1.3.3 Global Docetaxel Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Docetaxel Sales Breakdown by Type (2018-2023)
1.4.2 Europe Docetaxel Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Docetaxel Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Docetaxel Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Docetaxel Sales Breakdown by Type (2018-2023)
2 Global Docetaxel Market Competition by Company
2.1 Global Top Players by Docetaxel Sales (2018-2023)
2.2 Global Top Players by Docetaxel Revenue (2018-2023)
2.3 Global Top Players by Docetaxel Price (2018-2023)
2.4 Global Top Manufacturers Docetaxel Manufacturing Base Distribution, Sales Area, Product Type
2.5 Docetaxel Market Competitive Situation and Trends
2.5.1 Docetaxel Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Docetaxel Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Docetaxel as of 2022)
2.7 Date of Key Manufacturers Enter into Docetaxel Market
2.8 Key Manufacturers Docetaxel Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Docetaxel Status and Outlook by Region
3.1 Global Docetaxel Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Docetaxel Historic Market Size by Region
3.2.1 Global Docetaxel Sales in Volume by Region (2018-2023)
3.2.2 Global Docetaxel Sales in Value by Region (2018-2023)
3.2.3 Global Docetaxel Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Docetaxel Forecasted Market Size by Region
3.3.1 Global Docetaxel Sales in Volume by Region (2024-2029)
3.3.2 Global Docetaxel Sales in Value by Region (2024-2029)
3.3.3 Global Docetaxel Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Docetaxel by Application
4.1 Docetaxel Market Segment by Application
4.1.1 Breast Cancer
4.1.2 Prostate Cancer
4.1.3 Non-small Cell Lung Cancer
4.1.4 Others
4.2 Global Docetaxel Market Size by Application
4.2.1 Global Docetaxel Market Size Overview by Application (2018-2029)
4.2.2 Global Docetaxel Historic Market Size Review by Application (2018-2023)
4.2.3 Global Docetaxel Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Docetaxel Sales Breakdown by Application (2018-2023)
4.3.2 Europe Docetaxel Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Docetaxel Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Docetaxel Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Docetaxel Sales Breakdown by Application (2018-2023)
5 North America Docetaxel by Country
5.1 North America Docetaxel Historic Market Size by Country
5.1.1 North America Docetaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Docetaxel Sales in Volume by Country (2018-2023)
5.1.3 North America Docetaxel Sales in Value by Country (2018-2023)
5.2 North America Docetaxel Forecasted Market Size by Country
5.2.1 North America Docetaxel Sales in Volume by Country (2024-2029)
5.2.2 North America Docetaxel Sales in Value by Country (2024-2029)
6 Europe Docetaxel by Country
6.1 Europe Docetaxel Historic Market Size by Country
6.1.1 Europe Docetaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Docetaxel Sales in Volume by Country (2018-2023)
6.1.3 Europe Docetaxel Sales in Value by Country (2018-2023)
6.2 Europe Docetaxel Forecasted Market Size by Country
6.2.1 Europe Docetaxel Sales in Volume by Country (2024-2029)
6.2.2 Europe Docetaxel Sales in Value by Country (2024-2029)
7 Asia-Pacific Docetaxel by Region
7.1 Asia-Pacific Docetaxel Historic Market Size by Region
7.1.1 Asia-Pacific Docetaxel Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Docetaxel Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Docetaxel Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Docetaxel Forecasted Market Size by Region
7.2.1 Asia-Pacific Docetaxel Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Docetaxel Sales in Value by Region (2024-2029)
8 Latin America Docetaxel by Country
8.1 Latin America Docetaxel Historic Market Size by Country
8.1.1 Latin America Docetaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Docetaxel Sales in Volume by Country (2018-2023)
8.1.3 Latin America Docetaxel Sales in Value by Country (2018-2023)
8.2 Latin America Docetaxel Forecasted Market Size by Country
8.2.1 Latin America Docetaxel Sales in Volume by Country (2024-2029)
8.2.2 Latin America Docetaxel Sales in Value by Country (2024-2029)
9 Middle East and Africa Docetaxel by Country
9.1 Middle East and Africa Docetaxel Historic Market Size by Country
9.1.1 Middle East and Africa Docetaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Docetaxel Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Docetaxel Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Docetaxel Forecasted Market Size by Country
9.2.1 Middle East and Africa Docetaxel Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Docetaxel Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hengrui Medicine
10.1.1 Hengrui Medicine Company Information
10.1.2 Hengrui Medicine Introduction and Business Overview
10.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Hengrui Medicine Docetaxel Products Offered
10.1.5 Hengrui Medicine Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Docetaxel Products Offered
10.2.5 Sanofi Recent Development
10.3 Qilu Pharma
10.3.1 Qilu Pharma Company Information
10.3.2 Qilu Pharma Introduction and Business Overview
10.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Qilu Pharma Docetaxel Products Offered
10.3.5 Qilu Pharma Recent Development
10.4 Shenzhen Main Luck Pharma
10.4.1 Shenzhen Main Luck Pharma Company Information
10.4.2 Shenzhen Main Luck Pharma Introduction and Business Overview
10.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shenzhen Main Luck Pharma Docetaxel Products Offered
10.4.5 Shenzhen Main Luck Pharma Recent Development
10.5 Jiangsu Aosaikang Pharma
10.5.1 Jiangsu Aosaikang Pharma Company Information
10.5.2 Jiangsu Aosaikang Pharma Introduction and Business Overview
10.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jiangsu Aosaikang Pharma Docetaxel Products Offered
10.5.5 Jiangsu Aosaikang Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Docetaxel Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Docetaxel Industrial Chain Analysis
11.4 Docetaxel Market Dynamics
11.4.1 Docetaxel Industry Trends
11.4.2 Docetaxel Market Drivers
11.4.3 Docetaxel Market Challenges
11.4.4 Docetaxel Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Docetaxel Distributors
12.3 Docetaxel Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
